Literature DB >> 26221235

Qian Five Rhinoceros Gindeng (QFRG) protects against development of immune thrombocytopenia via miR-181a inhibition of TLR-4 expression.

Yu-Zhou He1, Ru-Feng Lu1, Chen Zhu1, Jun-Yi Hua1.   

Abstract

AIMS: Traditional Chinese medicine (TCM) has been considered to be effective auxiliary strategy for the treatment of hemocytopenia including immune thrombocytopenia. However, the molecular mechanism is still not understood.
METHODS: In present study, Qian Five Rhinoceros Gindeng (QFRG) mainly containing buffalo horn, rehmannia root, radix rubia, trogopterus dung and radix salviae miltiorrhizae administrated to thrombocytopenia mice induced by injection of MWReg30. MicroRNAs (miRNAs), Toll Like Receptors (TLRs) and cytokines were assayed in monocytes separated from mice peripheral blood. The relationship between miRNAs and TLRs was investigated in Mouse leukaemic monocyte macrophage cell line RAW264.7.
RESULTS: The mice with administration of QFRG had a significant increase in platelet count, and miR-181a of monocytes was markedly up-regulated in QFRG treated group. QFRG also decreased the levels of TLR4, IL-6 and TNF-α. In addition, miR-181a inhibitor reversed the effects of QFRG on platelet count, TLR4 and cytokines. Overexpression of miR-181a in lipopolysaccharide-induced showed a decrease of TLR4, IL-6 and TNF-α level.
CONCLUSIONS: QFRG protects against development of immune thrombocytopenia via miR-181a inhibition of TLR-4 expression.

Entities:  

Keywords:  Rhinoceros horn; immune thrombocytopenia; toll like receptor; traditional Chinese medicine

Year:  2015        PMID: 26221235      PMCID: PMC4509180     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  28 in total

1.  Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.

Authors:  Dan-Xia Zhu; Kou-Rong Miao; Cheng Fang; Lei Fan; Wei Zhu; Hua-Yuan Zhu; Yun Zhuang; Ming Hong; Peng Liu; Wei Xu; Jian-Yong Li
Journal:  Leuk Res       Date:  2010-12-03       Impact factor: 3.156

2.  Association between microRNA polymorphisms and humoral immunity to hepatitis B vaccine.

Authors:  Yongzhen Xiong; Shengli Chen; Ruhong Chen; Weiyan Lin; Jindong Ni
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

Review 3.  MicroRNA expression in colorectal cancer.

Authors:  Niamh M Hogan; Myles R Joyce; Michael J Kerin
Journal:  Cancer Biomark       Date:  2012       Impact factor: 4.388

4.  Antipyretic and antioxidant activities of the aqueous extract of Cornu bubali (water buffalo horn).

Authors:  Rui Liu; Min Wang; Jin-Ao Duan
Journal:  Am J Chin Med       Date:  2010       Impact factor: 4.667

5.  Research and development of the effective components of panaxdiol saponin as new Chinese patent medicine for treating hemocytopenia.

Authors:  Rui-lan Gao; Beng Hock Chong
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

6.  Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia.

Authors:  Rong Deng; Joseph P Balthasar
Journal:  Blood       Date:  2006-11-28       Impact factor: 22.113

7.  MicroRNA-deficient Schwann cells display congenital hypomyelination.

Authors:  Beth Yun; Angela Anderegg; Daniela Menichella; Lawrence Wrabetz; M Laura Feltri; Rajeshwar Awatramani
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

8.  Pharmacokinetic and pharmacological interactions between ticlopidine hydrochloride and Kangen-Karyu - Chinese traditional herbal medicine.

Authors:  Toshiaki Makino; Hannosuke Wakushima; Takuya Okamoto; Yasuhiro Okukubo; Yoshiharu Deguchi; Yoshihiro Kano
Journal:  Phytother Res       Date:  2003-11       Impact factor: 5.878

Review 9.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

10.  MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP).

Authors:  Margareta Jernås; Intawat Nookaew; Hans Wadenvik; Bob Olsson
Journal:  Blood       Date:  2013-01-09       Impact factor: 22.113

View more
  4 in total

1.  Clinical significance of miR-181a in patients with neonatal sepsis and its regulatory role in the lipopolysaccharide-induced inflammatory response.

Authors:  Guozhi Liu; Wei Liu; Jie Guo
Journal:  Exp Ther Med       Date:  2020-01-02       Impact factor: 2.447

Review 2.  The Extensive Regulation of MicroRNA in Immune Thrombocytopenia.

Authors:  Yuerong Zhao; Siyuan Cui; Yan Wang; Ruirong Xu
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

3.  MicroRNA-181b negatively regulates the proliferation of human epidermal keratinocytes in psoriasis through targeting TLR4.

Authors:  Cheng Feng; Ming Bai; Nan-Ze Yu; Xiao-Jun Wang; Zeng Liu
Journal:  J Cell Mol Med       Date:  2016-09-19       Impact factor: 5.310

4.  Elucidation of the Mechanisms and Molecular Targets of Yiqi Shexue Formula for Treatment of Primary Immune Thrombocytopenia Based on Network Pharmacology.

Authors:  Yunyao Jiang; Nan Liu; Shirong Zhu; Xiaomei Hu; Dennis Chang; Jianxun Liu
Journal:  Front Pharmacol       Date:  2019-10-01       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.